Bowel biopsy

While the jejunal mucosa of the adult cases was normal, the mucosa of the rectum showed the histological picture of lipid deposition in foam cells, and there was an orange-yellow tinge and tiny, flat, red-brown spots (Hoffman and Fredrickson 1965, Fredrickson 1966). 

Lymph node biopsy showed marked fatty degeneration. Other organs were not examined in TD. There was no autopsy in the only fatal case. 

Spleen showing lipid-filled reticulo-endothelial cells of pulp. Hematoxylin and eosin stain, original magnification x 250. Case 1 from Hoffman and Fredrickson (1965). (Reproduced with kind permission of The American Journal of Medicine and the authors) 

Exhaustive plasma lipid analyses of all six cases were performed by Fredrickson s group at the National Institutes of Health, and in addition, tonsillar lipids were studied in three cases and lipids of spleen and lymph nodes in one case. 

The most significant plasma lipid abnormality is a decreased cholesterol level. The lowest values are below 50 mg per 100 ml similarly low levels are found 

---

In some cases, invasive tests such as endoscopy are needed. For most gastroenterological allergies, small bowel biopsy shows a patchy enteropathy with nonspecific inflammatory infiltrate (lymphocytes, monocytes, eosinophils). If the diagnosis is positive, the mucosa improves when the offending proteins are removed from the diet. Histology of the biopsy samples often confirms the diagnosis but does not indicate which foods are responsible for the reaction (Sampson, 2004). 

Barker CC, Mitton C, Jevon G, Mock T. Can tissue transglutaminase antibody titers replace small-bowel biopsy to diagnose celiac disease in select pediatric populations Pediatrics 2005 115 1341-1346. 

A 63-year-old hjrpertensive woman, who had a carcinoma of the distal esophagus resected 19 months earlier, developed chronic diarrhea. Clostridium difficile toxin was identified in her stools and the diarrhea resolved after treatment with metronidazole. Enalapril was added to her antihypertensive treatment, and 3 months later the diarrhea recurred. Stool examination was negative and there was no Clostridium difficile toxin. Her condition worsened and she lost 5 kg in weight She had marked eosinophiha (2.4 x 10 /1), and a small bowel biopsy showed mild chronic inflammation and edema, partial villous atrophy, and large clusters of eosinophils in the lamina propria with some focal infiltration of the epithelium. She stopped taking enalapril and her diarrhea promptly abated and the eosinophil count fell to 0.5 X 10 /1 at 3 weeks and 0.1 x 10 /1 at 2 months. 

Clinically, the most relevant symptoms are oedema, diarrhoea and lymphocytopenia due to both lymphatic leakage and rupture. The small bowel biopsy finding of numerous dilated lymphatic vessels consistent with diffuse or focal lymphangiectasia definitely support the diagnosis. 

Infliximab binds to the TNF-a on the surface of cells, inhibiting transmembrane TNF-a and inflammatory response (264,265). In bowel biopsies, infliximab caused apoptosis for inflammatory cells (266-268). In contrast, etanercept does not have this effect (266) this may in part explain the ineffectiveness of etanercept for Crohn s disease (269). Adalimumab and infliximab induced apoptosis in peripheral blood monocytes whereas etanercept did not (270,271). Both etanercept and infliximab induce apoptosis of macrophages in the synovium of patients with RA (272). 

Colon inflammation 1. AEA levels are elevated in the colon of DNBS-treated mice and in the colon submucosa of TNBS-treated rats, two animal models of inflammatory bowel diseases, and in the biopsies of patients with ulcerative colitis, to control inflammation 1. Inhibitors of degradation (both FAAH and cellular re-uptake)... 

Summary of Consequences for Intestinal Microflora Failure of intestinal clearance caused by impaired motor activity or local stagnation for anatomical reasons results in Gram-negative colonization of the small bowel. Small bowel aspirate, mucosal brush, or biopsies are optional samples for culture, which is still the gold standard for detecting this type of overgrowth. 

B16. Bolt, R. J., Pollard, H. M., and McCool, S., Staining of enzymes in mucosa of the small bowel, using a peroral biopsy tube. Am. J. Clin. Pathol. 34, 43-49 (1960). 

Sullivan, B. H., Jr., Sprinz, H., and Batsaki, J. G., Peroral small bowel mucosal biopsy. New investigative technics and experimentation have altered concepts of pathological changes and provided a tool for investigation of certain physiological processes. J. Am. Med. Assoc. 174, 2200-2203 (1960). 

Traditional endoscopic and surgical procedures provide whole tumor samples well suited for microscopic examination and analysis in the pathology laboratory. The use of whole tissue tumor biopsies for proteomic studies has, however, raised several important issues that have been well demonstrated in CRC [9]. These include cellular heterogeneity in the different bowel parietal layers (mucosa, submucosa, muscularis mucosa, serosa) that may or may not be infiltrated, epithelial cell diversity in the mucosa itself, tissue infiltration by inflammatory cells such as lymphocytes, contamination with other body fluids, and protein degradation following tumor necrosis. In fact, epithelial cell content was found to vary between 9 and 67% in whole biopsies of normal mucosa and between 7 and 95% in tumor biopsies [10]. This study clearly demonstrates the likelihood of large cellular variation between tissue samples. 

Protein Modeling on the Internet A group of patients with Crohn s disease (an inflammatory bowel disease) underwent biopsies of their intestinal mucosa in an attempt to identify the causative agent. Researchers identified a protein that was present at higher levels in patients with Crohn s disease than in patients with an unrelated inflammatory bowel disease or in unaffected controls. The protein was isolated, and the following partial amino acid sequence was obtained (reads left to right) ... 

A 55-year-old man with irritable bowel syndrome who took alosetron 1 mg bd for 4 days developed symptoms of ischemic colitis, including rectal bleeding, and the diagnosis was confirmed macroscopically and histologically at colonoscopy. The symptoms suggestive of colitis abated on withdrawal of alosetron, but the symptoms of irritable bowel syndrome returned. Colonoscopy 2 weeks later showed a normal colon and biopsies showed normal colonic histology. 

In a prospective prevalence study of liver disease in 90 patients with permanent intestinal failure receiving parenteral nutrition hver biopsy was performed in 57 (95). Chronic cholestasis developed in 58 patients after a median of 6 (range 3-132) months, and 37 developed comphcated liver disease after a median of 17 (range 2-155) months. Chronic cholestasis was significantly associated with a risk of liver disease independent of parenteral nutrition, a bowel remnant shorter than 50 cm, and a lipid intake of 1 g/kg/day or more hver disease related to parenteral nutrition was significantly associated with chronic cholestasis and a parenteral hpid intake of 1 g/kg/day or more. The authors concluded that the prevalence of hver disease increased with the duration of parenteral nutrition and was one of the main causes of death in patients with permanent intestinal failure. Parenteral intake of long-chain hpid emulsion should be restricted to less than 1 g/kg/day. 

---